Trulieve Cannabis (TRLV) Cost of Revenue (2020 - 2026)

Trulieve Cannabis (TRLV) has reported Cost of Revenue for 7 consecutive years, with $116.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cost of Revenue rose 1.86% year-over-year to $116.7 million; the TTM figure through Mar 2026 stood at $472.1 million (up 2.31% YoY), while the FY2025 annual figure was $470.0 million, changed 0.16% from the prior year.
• Cost of Revenue came in at $116.7 million for Q1 2026 at Trulieve Cannabis, down from $118.0 million in the prior quarter.
• The five-year high for Cost of Revenue was $359.4 million in Q4 2023, with the low at $59.4 million in Q3 2023.
• Average Cost of Revenue over 5 years is $136.7 million, with a median of $118.3 million recorded in 2025.
• Across the five-year window, Cost of Revenue soared 2363.55% in 2022 and sank 68.24% in 2024, its largest moves.
• Year by year, Cost of Revenue stood at $309.4 million in 2022, then grew by 16.14% to $359.4 million in 2023, then tumbled by 68.24% to $114.1 million in 2024, then advanced by 3.38% to $118.0 million in 2025, then dropped by 1.11% to $116.7 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $116.7 million, $118.0 million, and $118.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.